Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+ Lymphoma.

Sang, Wei; Wang, Xiangmin; Geng, Hongzhi; Li, Tianci; Li, Dashan; Zhang, Bingpei; Zhou, Yi; Song, Xuguang; Sun, Cai; Yan, Dongmei; Li, Depeng; Li, Zhenyu; Li, Caixia; Xu, Kailin

Sang, Wei; Wang, Xiangmin; Geng, Hongzhi; Li, Tianci; Li, Dashan; Zhang, Bingpei; Zhou, Yi; Song, Xuguang; Sun, Cai; Yan, Dongmei; Li, Depeng; Li, Zhenyu; Li, Caixia; Xu, Kailin.

Afiliação

Sang W; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Wang X; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.
Geng H; Key Laboratory of Bone Marrow Stem Cell, Xuzhou, China.
Li T; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Li D; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.
Zhang B; Key Laboratory of Bone Marrow Stem Cell, Xuzhou, China.
Zhou Y; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Song X; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Sun C; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.
Yan D; Key Laboratory of Bone Marrow Stem Cell, Xuzhou, China.
Li D; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Li Z; Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China.
Li C; Key Laboratory of Bone Marrow Stem Cell, Xuzhou, China.
Xu K; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Front Immunol ; 13: 858021, 2022.

Article em En | MEDLINE | ID: mdl-35432352

Assuntos

Linfoma Difuso de Grandes Células B; Receptores de Antígenos Quiméricos; Terapia Baseada em Transplante de Células e Tecidos; Síndrome da Liberação de Citocina; Humanos; Imunoterapia Adotiva/efeitos adversos; Antígeno Ki-1; Linfoma Difuso de Grandes Células B/terapia; Receptores de Antígenos Quiméricos/genética

Palavras-chave

CD30; PD-1; chimeric antigen receptor; efficacy; relapsed/refractory CD30+ lymphoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google